Cargando…
Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials
Autores principales: | Simmons, Cameron P., Wolbers, Marcel, Nguyen, Minh Nguyet, Whitehorn, Jamie, Shi, Pei Yong, Young, Paul, Petric, Rosemary, Nguyen, Van Vinh Chau, Farrar, Jeremy, Wills, Bridget |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459884/ https://www.ncbi.nlm.nih.gov/pubmed/23029567 http://dx.doi.org/10.1371/journal.pntd.0001752 |
Ejemplares similares
-
Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
por: Whitehorn, James, et al.
Publicado: (2012) -
Genetic Variants of MICB and PLCE1 and Associations with Non-Severe Dengue
por: Whitehorn, James, et al.
Publicado: (2013) -
Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam
por: Anders, Katherine L., et al.
Publicado: (2011) -
Considerations in the Design of Clinical Trials to Test Novel Entomological Approaches to Dengue Control
por: Wolbers, Marcel, et al.
Publicado: (2012) -
Clinical Features of Dengue in a Large Vietnamese Cohort: Intrinsically Lower Platelet Counts and Greater Risk for Bleeding in Adults than Children
por: Dinh The, Trung, et al.
Publicado: (2012)